SCHEMBL3946503

SCHEMBL3946503

CC(=O)NC1C[C@H](N(C)C(C)C)CCC1N1CCC(NC(=O)O)C1=O

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 20/20 0.59
CCR5 P51681 3/20 0.57
KCNH2 Q12809 6/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3946507 1.00 CCR2 (0.59) CCR2CCR5KCNH2
SCHEMBL2784969 1.00 CCR2 (0.59) CCR2CCR5KCNH2
SCHEMBL2784973 1.00 CCR2 (0.59) CCR2CCR5KCNH2
SCHEMBL2785217 1.00 CCR2 (0.59) CCR2CCR5KCNH2
SCHEMBL3256079 0.89 CCR2 (0.54) CCR2CCR5KCNH2
SCHEMBL3256072 0.89 CCR2 (0.54) CCR2CCR5KCNH2
SCHEMBL3250364 0.88 CCR2 (0.55) CCR2CCR5KCNH2
SCHEMBL3250362 0.88 CCR2 (0.55) CCR2CCR5KCNH2
SCHEMBL3746858 0.87 CCR2 (0.66) CCR2CCR5KCNH2
SCHEMBL3746851 0.87 CCR2 (0.66) CCR2CCR5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049519-A2 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Brystol-Myers Squibb Company (US) 2009-04-22 EP disclosed
EP-2049477-A2 MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESS Brystol-Myers Squibb Company (US) 2009-04-22 EP disclosed
WO-2008014381-A2 MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-01-31 WO disclosed
WO-2008014361-A2 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2008-01-31 WO disclosed